Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-03-01
2011-12-20
Shaw, Amanda (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S024330, C536S023100
Reexamination Certificate
active
08080371
ABSTRACT:
Correlations between polymorphisms and addiction are provided. Methods of diagnosing, prognosing, and treating addiction are provided. Systems and kits for diagnosis, prognosis and treatment of addiction are provided. Methods of identifying addiction modulators are also described.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 5045694 (1991-09-01), Beavis et al.
patent: 5202561 (1993-04-01), Giessmann et al.
patent: 5468613 (1995-11-01), Erlich et al.
patent: 5925517 (1999-07-01), Tyagi et al.
patent: 6037130 (2000-03-01), Tyagi et al.
patent: 6111251 (2000-08-01), Hillenkamp
patent: 6150097 (2000-11-01), Tyagi et al.
patent: 6174670 (2001-01-01), Wittwer et al.
patent: 6342355 (2002-01-01), Hacia et al.
patent: 6740510 (2004-05-01), Kautzer et al.
patent: 6897025 (2005-05-01), Cox et al.
patent: 6898531 (2005-05-01), Sheehan et al.
patent: 6969589 (2005-11-01), Patil et al.
patent: 7127355 (2006-10-01), Cox et al.
patent: 2003/0108919 (2003-06-01), Kautzer et al.
patent: 2004/0023237 (2004-02-01), Patil et al.
patent: 2004/0229224 (2004-11-01), Frazer et al.
patent: 2004/0241657 (2004-12-01), Patil et al.
patent: 2005/0003410 (2005-01-01), Frazer et al.
patent: 2005/0007375 (2005-01-01), Yi
patent: 2005/0019787 (2005-01-01), Berno et al.
patent: 2006/0166224 (2006-07-01), Norviel
patent: WO92/02638 (1992-02-01), None
Langdahl, Bente et al. Osteoporotic fractures are assoicated with an 86 base pair repeat polymoprhism in the interleukin 1 receptor antagonist gene but not with polymoprhisms in the interleukin 1B gene. 2000. Journal of Bone and Mineral Research. vol. 15 No. 3 pp. 402-414.
Wall, Jeffery et al. Haplotype blocks and linkage disequilbirium in the human genome. 2003. Nature Reviews Genetics. vol. 4 pp. 587-597.
Arnhelm, N., et al.,C&EN—36-47 (1990).
Barrett ,J.C., et al.,Bioinformatics—21(2):263-265 (2005).
Barringer, K.J., et al.,Gene—89:117-122 (1990).
Beaucage, S.L., et al.,Tetrahedron Letts.—22(20):1859-1862 (1981).
Becker, J., et al.,Mol Gen Genet—249:65-73 (1995).
Benjamini, Y., et al.,J.R. Stat. Soc. B—57(1):289-300 (1995).
Beuten, J., et al.,Am. J. Hum. Genet.—76:859-864 (2005).
Beuten, J., et al.,Am. J. Med. Genet. B Neuropsychiatr. Genet.—139:73-80 (2005).
Bierut, L.J. et al.,Hum. Mot. Genet.—16(1):24-35 (2007).
Bierut, L.J., et al.,Am. J. Med. Genet.—124A:19-27 (2004).
Bierut, L.J., et al.,Arch. Gen. Psychiatry—-55:982-988 (1998).
Blok, H.J., et al.,Mol Cell Probes—11:187-194 (1997).
Bonnet, G., et al.,Proc. Natl. Acad. Sci. U.S.A.—96:6171-6176 (1999).
Boustead. C, et al.,Pharmacogenetics—7:411-414 (1997).
Breslau, N., et al.,Psychol. Med.—34:323-333 (2004).
Breslau, N., et al.,Biol. Psychiatry—55:69-76 (2004).
Breslau, N., et al.,Am. J. Public Health—90:1122-1127 (2000).
Busby, V., et al.,Neuromolecular Med.—5:133-146 (2004).
Butt, C.M., et al,Alcohol. Clin. Exp. Res.—27(5):733-742 (2003).
Butt, C.M., et al.,Behav. Neurosci.—119(1):26-37 (2005).
CDC (2005) Annual smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 1997-2001—Morbidity&Mortality Weekly Report—54:625-628.
CDC (2005) Cigarette smoking among adults—United States, 2004—Morbidity&Mortality Weekly Report—54:121-1124.
CDC (2004) Cigarette use among high school students—United States, 1991-2003—Morbidity&Mortality Weekly Report—53:499-502.
Carlson, C.S., et al.,Am. J. Hum. Genet.—74:106-120 (2004).
Carmelli, D., et al.,N. Engl. J. Med.—327(12):829-833 (1992) Abstract Only.
Chee, M., et al., Science—274:610-614 (1996).
Cheng, S., et al.,Nature—369:684-685 (1994).
Cholerton, S., et al.,Pharmacogenetics—6:261-263 (1996).
Comings, D.E., et al.,Pharmacogenetics—6:73-79(1996).
Corrigall, W.A., et al.,Brain. Res.—653:278-284 (1994).
Craig, A.M., et al.,Trends Neurosci.—29:8-20 (2006).
Cserzo, M., et al.,Protein Eng.—10(6):673-676 (1997).
Dobelis, P., et al.,Mol. Pharmacol.—62(2):334-342 (2002).
Dobson-Stone, C., et al.,Eur. J. Hum. Genet.—10:773-781 (2002).
Ertekin-Taner, N., et al.,Hum. Mol. Genet.—12,3133-3143 (2003).
Fang, X. ,et al.J. Am. Chem. Soc.—121:2921-2922 (1999).
Feng, Y., et al.,Am. J. Hum. Genet.—75:112-121 (2004).
Zeng, Z., et al.,Cell—127:621-633 (2006).
Fodor, P.A.,FASEB Journal—11:A879 (1997).
Fodor, S.P.A.Science—277:393-395 (1997).
Gelernter, J. et al.,Am. J. Med. Genet. B Neuropsychiatr. Genet.—128B:94-101 (2004).
Grant, B.F., et al.,Arch. Gen. Psychiatry—61:1107-1115 (2004).
Greenbaum, L., et al.,Mol. Psychiatr.—11:312-322 (2006).
Guatelli, J.C., et al.,Proc. Natl. Acad. Sci. USA—87:1874-1878 (1990).
Heath, A.C., et al.,Addict. Behav.—18:19-34 (1993).
Heatherton, T.F., et al.,Br. J. Addict.—86:1119-1127 (1991).
Heatherton, T.F., et al.,Br. J. Addict.—84:791-800 (1989).
Hegab, A.E., et al.,J. Med. Genet.—41:(e27):1-7 (2004).
Hinds, D.A., et al.,Science—307:1072-1 079 (2005).
Hinds, D.A., et al.,Am. J. Hum. Genet.—74:317-325 (2004).
Hochberg, Y., et al.,Stat. Med.—9:811-818 (1990).
Hsuih, T.C.H., et al.,J. Clin. Microbiol.—34(3):501-507 (1996).
Hu, S., et al.,Mol. Psychiatry—5:181-188 (2000).
Iacono, W.G., et al.,Arch. Gen. Psychiatry—59,750-757 (2002).
Issaq, H.J., et al., (Analytical Chemistry—75:149A-155A (2003).
Jeulin, C., et al.,Am. J. Physiol. Lung Cell. Mol. Physiol.—289:L636-L646 (2005).
Karadsheh, M. S., et al.,J. Neurochem.—91:1138-1150 (2004).
Kostrikis, L.G., et al.,Science—279:1228-1229 (1998).
Kwoh, D.Y., et al.,Proc. Natl. Acad. Sci. USA—86:1173-1177 (1989).
Landegren, U., et al.,Science—241, 1077-1080 (1988).
Lasser, K, et al.,Jama—284(20):,2606-2610 (2000).
Laviolette,S.R., et al.,Nat. Rev. Neurosci.—5:55-65 (2004) Abstract Only.
Leone, G., et al.,Nucleic Acids Res.—26(9):2150-2155 (1998).
Lerman, C., et al.,Health Psychol.—18(1):14-20 (1999).
Lerman, C., et al.,Mol. Psychiatry—5:189-192 (2000).
Lessov, C.N., et al.,Psychol. Med.—34, 865-879 (2004).
Lewohl, J.M., et al.,Nat. Neurosci.—2(12):1084-1090 (1999).
Li, M.D., et al.,BMC Genet.—4(Suppl I):SI03:1-5 (2003).
Li, M.D., et al.,Hum. Mol. Genet.—14:1211-1219 (2005).
Li, M.D.,Curr. Psychiatry. Rep.—8:158-164 (2006).
Lindstrom, J.M., et al.,Ann. N.Y. Acad. Sci.—998:41-52 (2003).
Liu, Q.R., et al.,Proc. Natl. Acad. Sci. U. S. A.—102:11864-11869 (2005).
Lockhart, D.J.,Nature Medicine—4:1235-1236 (1998).
Lomell, H., et al.,J. Clin. Chem.—35:1826-1831 (1989).
Lowry, O. H., et al,.J. Biol. Chem.—193:265-275 (1951).
Ma, J.Z., et al.,Hum. Mol. Genet.—14(12):1691-1698 (2005).
Madden, P.A., et al.,Behav. Genet.—29(6):423-431 (1999).
Marks, M. J., et al.,J. Pharmacol. Exp. Ther.—285(1):377-386 (1998).
Marras, S.A.E., et al.,Genet. Anal. Biomol. Eng.—14:151-156 (1999).
Meksem, K., et al.,Mol. Gen. Genet.—249:74-81 (1995).
Merikangas, K.R., et al.,Arch Gen Psychiatryi—55:973-979 (1998).
Needham-VanDevanter, D.R., et al.,Nucleic Acids Res.—12(15):6159-6168 (1984).
Pianezza, M.L., et al. Sellers,E.M., and Tyndale,RF. Nicotine metabolism defect reduces smoking.Nature—393:750 (1998).
Pritchard, J.K., et al.,Genetics Society of America—155:945-959 (2000).
Roeder, K., et al.,Am. J. Hum. Genet.—78, 243-252 (2006).
Saccone, S.F., et al.,Genet. Epidemiol.—30:459-470 (2006).
Saccone, S.F., et al.,Hum. Mol. Genet.—16(1):36-49 (2006).
Salminen, O., et al.,Mol. Pharmacol.—65(6):1526-1535 (2004).
Sapolsky, R.J., et al.,Genetic Analysis: Biomolecular Engineering—14:187-192 (1999).
Satagopan, J.M., et al.,Biometrics—58:163-170 (2002).
(Service (1998) Science 282:396-401(1998).
Shields, P.G., et al.,Cancer Epi
Ballinger Dennis
Bierut Laura Jean
Goate Alison M.
Hinrichs Anthony L.
Konvicka Karel
Shaw Amanda
The Washington University
LandOfFree
Markers for addiction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Markers for addiction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers for addiction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262169